INCYTE CORP

Route 141 & Henry Clay Rd, Bldg E336 Ticker: INCY
Wilmington , DE 19804 Exchange: NASD
302-498-6700 Sector: Health Care
Industry: Biotechnology

Complete Financials: Q2Y08 Currency: USD Current Annual Period: Y07
Business Summary
INCY Incyte Corporation operates as a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases.


RATIOS AND STATISTICS AT A GLANCE
( As of 10/13/2008 )
Price

52 Week High

52 Week Low

3 Month Avg Daily Vol (Mil)

10 Day Avg Daily Vol (Mil)

Beta

Indicated Annual Dividend

Dividend Yield % 		4.630

12.830

4.620

1.208

1.624

2.148

0.000

0.000 		Price/Sales (TTM)

P/E Ratio (TTM)

Price/Book (MRQ)

Price/Cash Flow (TTM)

Return on Assets (TTM) %

Return on Equity (TTM) %

Current Ratio (MRQ)

Total Debt/Equity (MRQ) 		21.435

NC

-3.080

2.115

-52.800

71.823

4.659

-1.650

Note:
Mil = Millions
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months


SHARE RELATED INFORMATION SHORT INTEREST INFORMATION
Market Cap (Mil)

Shares Outstanding (Mil)

Float (Mil) 		442.119

95.490

55.961 		Current Month (Mil)

Previous Month (Mil)

Short Interest Ratio (Days) 		15.689

16.506

NA


INSTITUTIONAL &
INSIDER OWNERSHIP 		PURCHASES
(Mil) 		SALES
(Mil) 		NET PURCHASES
(Mil) 		PERCENT
OWNED (%) 		PREVIOUS PERCENT
OWNED (%)
Institutions (3 Months)

Insiders (6 Months) 		7.474

1.100 		-9.685

0.000 		-2.211

1.100 		103.704

21.928 		106.777

NA


GROWTH RATES 1 YEAR 3 YEAR 5 YEAR
Sales %

EPS %

Dividend % 		24.589

NC

NC 		34.527

NC

NC 		-19.458

NC

NC


HISTORICAL QUARTERLY RESULTS

REVENUE
( Thousands of USD )
QUARTERS 2005 2006 2007 2008
Q1

Q2

Q3

Q4 		2.915

2.676

1.227

1.028 		6.465

6.855

7.267

7.056 		7.422

10.576

6.690

9.752 		1.307

0.613



TOTAL 7.846 27.643 34.440
EARNINGS PER SHARE
( USD )
QUARTERS 2005 2006 2007 2008
Q1

Q2

Q3

Q4 		-0.240

-0.300

-0.360

-0.330 		-0.210

-0.240

-0.190

-0.240 		-0.260

-0.220

-0.290

-0.260 		-0.470

-0.540



TOTAL -1.230 -0.880 -1.030

Copyright © 2008 , Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. Standard & Poor’s including its subsidiary corporations (“S&P”) is a division of The McGraw-Hill Companies, Inc. Reproduction of S&P Compustat in any form is prohibited except with the prior written permission of S&P. Because of the possibility of human or mechanical error by S&P’s sources, S&P or others, S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. S&P GIVES NO EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any indirect, special or consequential damages in connection with subscriber’s or others’ use of S&P Compustat.